Zaloguj Zarejestruj się zadarmo

Theratechnologies organizacji Akcje w obiegu

Jaka jest wartość Akcje w obiegu organizacji Theratechnologies?

Wartość Akcje w obiegu organizacji Theratechnologies, Inc. to 86.202M 90.60%

Jaka jest definicja Akcje w obiegu?

Akcje w obiegu (Shares float) jest częścią akcji korporacji, które znajdują się w rękach inwestorów publicznych, a nie w postaci zablokowanych zapasów.

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

Akcje w obiegu firm w Health Care sektor na TSX w porównaniu do Theratechnologies

Czym się zajmuję organizacja Theratechnologies?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Firmy z akcje w obiegu podobne do Theratechnologies